Status of HBV birth dose vaccination in Africa: the impact of COVID-19 and Gavi support on policy development.

Njuguna, Henry N; Hiebert, Lindsey; Gupta, Neil; Ward, John W

Njuguna, Henry N; Hiebert, Lindsey; Gupta, Neil; Ward, John W.

Njuguna HN; Coalition for Global Hepatitis Elimination, The Task Force for Global Health, Atlanta, GA, USA. Electronic address: hnjuguna@taskforce.org.
Hiebert L; Coalition for Global Hepatitis Elimination, The Task Force for Global Health, Atlanta, GA, USA.
Gupta N; Coalition for Global Hepatitis Elimination, The Task Force for Global Health, Atlanta, GA, USA.
Ward JW; Coalition for Global Hepatitis Elimination, The Task Force for Global Health, Atlanta, GA, USA.

Lancet Gastroenterol Hepatol ; 8(6): 502-503, 2023 06.

Article in English | MEDLINE | ID: covidwho-2274325

Subject(s)

COVID-19; Hepatitis B virus; Humans; COVID-19/epidemiology; COVID-19/prevention & control; Africa/epidemiology; Policy Making; Vaccination

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Hepatitis B virus / COVID-19 Type of study: Experimental Studies / Observational study Topics: Vaccines Limits: Humans Country/Region as subject: Africa Language: English Journal: Lancet Gastroenterol Hepatol Year: 2023 Document Type: Article

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google